Back to Search
Start Over
Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives.
- Source :
-
Archives of pharmacal research [Arch Pharm Res] 2018 Jul; Vol. 41 (7), pp. 725-736. Date of Electronic Publication: 2018 Jun 01. - Publication Year :
- 2018
-
Abstract
- Drug-induced diabetes is widely reported in clinical conditions, and it is becoming a global issue because of its potential to increase the risk of severe cardiovascular complications. However, which drug mechanisms exert their diabetogenic effects and why the effects present significant inter-individual differences remain largely unknown. Pharmacogenomics, which is the study of how genomic variation influences drug responses, provides an explanation for individual differences in drug-induced diabetes. We highlight that pharmacogenomics can be involved in regulating the expression of genes in signaling pathways related to the pharmacokinetics or pharmacodynamics of drugs or the pathogenesis of diabetes, contributing to the differences in drug-induced glucose impairment. The pharmacogenomics studies of the major diabetogenic drugs are reviewed, including calcineurin inhibitors, antipsychotics, hormones, and antihypertensive drugs. We intend to elucidate the genetic basis of drug-induced diabetes and pave the way for the precise use of these drugs in the clinic.
Details
- Language :
- English
- ISSN :
- 1976-3786
- Volume :
- 41
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Archives of pharmacal research
- Publication Type :
- Academic Journal
- Accession number :
- 29858981
- Full Text :
- https://doi.org/10.1007/s12272-018-1039-x